| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Oncology Institute, Inc.
13D/A
DFPH · 23343Q100
|
4.9% |
5/15/2026
Event 5/14/2026
|
||||
| M33 Growth I L.P. | 4.9% | |||||
| M33 Growth I GP LLC | 4.9% | |||||
| Toi M, LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.